Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

About: Cediranib

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Cediranib (AZD-2171; tentative trade name Recentin) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. The drug is being developed by AstraZeneca as a possible anti-cancer chemotherapeutic agent for oral administration.

Property Value
dbo:abstract
  • Cediranib (AZD-2171; tentative trade name Recentin) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. The drug is being developed by AstraZeneca as a possible anti-cancer chemotherapeutic agent for oral administration. (en)
  • Le cediranib est un inhibiteur des récepteurs à activité tyrosine kinase pour le facteur de croissance de l’endothélium vasculaire et en cours de tests dans des chimiothérapie anti-cancéreuse. (fr)
dbo:casNumber
  • 288383-20-0
dbo:chEMBL
  • 491473
dbo:fdaUniiCode
  • NQU9IPY4K9
dbo:kegg
  • D08881
dbo:pubchem
  • 9933475
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 10129400 (xsd:integer)
dbo:wikiPageLength
  • 8333 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1115433199 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • L01 (en)
dbp:atcSuffix
  • EK02 (en)
dbp:c
  • 25 (xsd:integer)
dbp:casNumber
  • 288383 (xsd:integer)
dbp:chembl
  • 491473 (xsd:integer)
dbp:chemspiderid
  • 8109103 (xsd:integer)
dbp:eliminationHalfLife
  • 126000.0 (dbd:second)
dbp:f
  • 1 (xsd:integer)
dbp:h
  • 27 (xsd:integer)
dbp:iupacName
  • 4 (xsd:integer)
dbp:iupharLigand
  • 5664 (xsd:integer)
dbp:kegg
  • D08881 (en)
dbp:n
  • 4 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 9933475 (xsd:integer)
dbp:routesOfAdministration
  • Oral (en)
dbp:smiles
  • COc4cc3cncnc3cc4OCCCN5CCCC5 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • XXJWYDDUDKYVKI-UHFFFAOYSA-N (en)
dbp:unii
  • NQU9IPY4K9 (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 449572361 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Cediranib (AZD-2171; tentative trade name Recentin) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. The drug is being developed by AstraZeneca as a possible anti-cancer chemotherapeutic agent for oral administration. (en)
  • Le cediranib est un inhibiteur des récepteurs à activité tyrosine kinase pour le facteur de croissance de l’endothélium vasculaire et en cours de tests dans des chimiothérapie anti-cancéreuse. (fr)
rdfs:label
  • Cediranib (en)
  • Cediranib (fr)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License